Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemolytic Disease of the Newborn”

568 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 568 results

Not applicableStudy completedNCT02770534
What this trial is testing

Evaluating Thromboelastography (TEG) and ETP in Sickle Adults

Who this might be right for
Sickle Cell Disease
Guy's and St Thomas' NHS Foundation Trust 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT06315920
What this trial is testing

Analgesic Effect of Parecoxib Versus Morphine in SCD Patients Presenting to the Emergency Department

Who this might be right for
Sickle-Cell Disease with Crisis
Oman Medical Speciality Board 226
Not applicableNot Yet RecruitingNCT07351435
What this trial is testing

The Caribbean Registry of Extracorporeal Membrane Oxygenation (ECMO) From the University Hospital in Martinique

Who this might be right for
Cardiogenic ShockMalignant ArrhythmiasIschemic or Valvular Heart Failure+8 more
University of Genova 1,200
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Testing effectiveness (Phase 2)Looking for participantsNCT06364774
What this trial is testing

ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia

Who this might be right for
Beta-Thalassemia
Children's Hospital of Philadelphia 12
Testing effectiveness (Phase 2)Study completedNCT04514510
What this trial is testing

Fixed Dose Flavonoid Isoquercetin on Thrombo-Inflammatory Biomarkers in Subjects With Stable Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 46
Not applicableUnknownNCT05788562
What this trial is testing

The Relevance Between the Level of Fetal Hemoglobin and Short-term Complications in Extremely Preterm Infants

Who this might be right for
Fetal Hemoglobin
The First Hospital of Jilin University 92
Not applicableUnknownNCT04310059
What this trial is testing

Effect of Folic Acid Supplementation in Pregnant Women Having Thalassaemia Trait

Who this might be right for
ThalassemiaFolic Acid Deficiency Anemia
The University of Hong Kong 270
Large-scale testing (Phase 3)Ended earlyNCT01425307
What this trial is testing

Transcranial Doppler (TCD) With Transfusions Changing to Hydroxyurea

Who this might be right for
Sickle Cell Anemia
Children's Hospital Medical Center, Cincinnati 159
Not applicableUnknownNCT05617612
What this trial is testing

Neonatal Cord Blood Screening for HDN

Who this might be right for
HDN - Hemolytic Disease of the Newborn
Assiut University 400
Not applicableStudy completedNCT02022891
What this trial is testing

Systematic Psychological and Medical Care for Children With SCD

Who this might be right for
Anemia, Sickle Cell
Fondation Ophtalmologique Adolphe de Rothschild 160
Testing effectiveness (Phase 2)Study completedNCT01703104
What this trial is testing

The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell Anemia

Who this might be right for
Sickle Cell Anemia
Lagos State University 150
Testing effectiveness (Phase 2)UnknownNCT03062501
What this trial is testing

Hydroxyurea in the Emergency Room to Lessen Pain in Sickle Cell Crisis

Who this might be right for
Anemia, Sickle CellAnemia; Sickle-Cell, With Crisis
Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti 30
Not applicableWithdrawnNCT03401125
What this trial is testing

Risk Factors for Allo-immunization in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Hanane EL KENZ
Large-scale testing (Phase 3)Study completedNCT01033747
What this trial is testing

Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study

Who this might be right for
Liver Iron Overload
Novartis Pharmaceuticals 70
Large-scale testing (Phase 3)Ended earlyNCT02433158
What this trial is testing

Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease

Who this might be right for
Sickle Cell AnemiaSickle Cell DiseaseSickle Cell Disorders+2 more
GlycoMimetics Incorporated 154
Post-approval studies (Phase 4)Study completedNCT00564941
What this trial is testing

Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload

Who this might be right for
Myelodysplastic SyndromesBeta-Thalassemia
Novartis Pharmaceuticals 309
Not applicableUnknownNCT05370677
What this trial is testing

The Prevelence of IVS 1-6 (T-C) [HBB:c.92 +6 T-C] Gene Mutation in Suspected Cases of β Thalassemia in Assiut University Hospitals

Who this might be right for
Beta-Thalassemia
Assiut University 141
Post-approval studies (Phase 4)Study completedNCT00243542
What this trial is testing

Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency

Who this might be right for
Acne Vulgaris
Allergan 64
Testing effectiveness (Phase 2)Ended earlyNCT00773890
What this trial is testing

TRF-1101 Assessment in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
TRF Pharma, Inc 80
Next Page